chrisvoncsefalvay/vaers-outcomes huggingface dataset:
became nervous and went to the emergency room on Sunday in which they sent her home; Has blisters in back of throat; Neck is "so sore and swollen"; Neck is swollen; Throat is so sore it hurts to swallow; Throat is so sore it hurts to swallow; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL BLISTERING (Has blisters in back of throat) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jul-2021, the patient experienced OROPHARYNGEAL BLISTERING (Has blisters in back of throat) (seriousness criterion medically significant), NECK PAIN (Neck is "so sore and swollen"), SWELLING (Neck is swollen), OROPHARYNGEAL PAIN (Throat is so sore it hurts to swallow) and ODYNOPHAGIA (Throat is so sore it hurts to swallow). On 01-Aug-2021, the patient experienced NERVOUSNESS (became nervous and went to the emergency room on Sunday in which they sent her home). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at an unspecified dose and frequency and IBUPROFEN for Adverse reaction, at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL BLISTERING (Has blisters in back of throat), NECK PAIN (Neck is "so sore and swollen"), SWELLING (Neck is swollen), OROPHARYNGEAL PAIN (Throat is so sore it hurts to swallow), ODYNOPHAGIA (Throat is so sore it hurts to swallow) and NERVOUSNESS (became nervous and went to the emergency room on Sunday in which they sent her home) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Aug-2021, COVID-19: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional treatment included a salt water gargle.    Concomitant medication use included prescribed medications and supplements for which details were not provided.  On 01-Aug-2021, the patient went to the emergency room and took a Strep throat test which came negative and patient was sent home.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-273688 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient jerked backwards, went rigid and fell straight back on her head on a concrete carpeted floor.  Patient lost conciousness for a few seconds, and regained orientation thereafter.  She was given orange juice, and laid on her back.  Paramedics were present and assessed her head injury and transported the patient to the nearby Hospital.
Dose was administered subcutaneously instead of intramuscularly . Contacted Sanofi manufacturer and representative stated that the vaccine may not be as efficacious since it was administered incorrectly. I contacted the patient to let him know of the incorrect administration site and offered to readminister vaccine correctly free of charge. Patient asked if it is necessary to get the vaccine again and stated he will not be able to come in to get a new dose. Patient reported having a sore arm but mentioned the site of reaction did not appear red, irritated, or itchy.
Complains of Headaches  consistantly  after a shot.  1 week after use Suggested going to a primary MD for follow up.
fever; Pressure in my head; dizziness; Headaches; sinus pressure; body aches in my upper back, arms and fingers; chills; This is a spontaneous report from a contactable a nurse, the patient.   A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, in the right arm on 18Feb2021 at 09:00 AM (at the age of 74-years-old) (Batch/Lot Number: EN6200) as a single dose for COVID-19 immunisation. Medical history included migraine from an unknown date and unknown if ongoing, psoriasis from an unknown date and unknown if ongoing, and allergy to penicilin and sulfa drugs, from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient previously received the first dose of BNT162b2 on 29Jan2021 at 09:00 (Lot Number: EL3249) for COVID-19 immunisation.  Concomitant medications included estradiol for an unspecified indication, start and stop date were not reported; levothyroxine for an unspecified indication, start and stop date were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 18Feb2021, at 09:30 AM, the patient experienced the events, fever, pressure in head, dizziness, Headaches, sinus pressure, body aches in upper back, arms and fingers, chills. The patient did not receive treatment for the events. The patient was recovering from the events, fever, pressure in head, dizziness, headaches, sinus pressure, body aches in upper back, arms and fingers, and chills.
Received some Moderna COVID19 doses that were expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received some Moderna COVID19 doses that were expired) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received some Moderna COVID19 doses that were expired). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received some Moderna COVID19 doses that were expired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  It was reported that the patient had additional dose.The vial was initially stored in the refrigerator on 31 Aug 2021.The vial  did not undergo any temperature excursions.  No treatment medication was reported   This case was linked to MOD-2022-534284 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2022: Follow up was received and contains  non significant information.
Patient received first dose of MODERNA on 4/6/21 at store pharmacy and had missed his appointment for his second dose. He went online and made an appointment in one store's COVID Vaccine scheduler and mistakenly made an appointment at another store pharmacy for 2nd dose of PFIZER. Discrepancy was not caught by pharmacy team and vaccine was administered. Patient called pharmacy on 5/10/21 at around 12PM questioning why 2 different vaccines were listed on the COVID 19 Vaccine record card. Customer was informed that he should not have received PFIZER and that he should have received MODERNA. Explained to customer that current recommendation from CDC is to not receive any additional doses of COVID vaccine at this time.
Turned red and still swollen; Fever in arm / Hot to touch / uncomfortable; Swelling; uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Turned red and still swollen), VACCINATION SITE WARMTH (Fever in arm / Hot to touch / uncomfortable), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (uncomfortable) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037k20a and 032L20a) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Turned red and still swollen), VACCINATION SITE WARMTH (Fever in arm / Hot to touch / uncomfortable), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (uncomfortable). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Turned red and still swollen), VACCINATION SITE WARMTH (Fever in arm / Hot to touch / uncomfortable), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (uncomfortable) outcome was unknown.            Concomitant medications include cholesterol meds, blood pressure meds, kidney meds and glaucoma eye drops.   This case was linked to MOD-2021-031107 (Patient Link).
About 3 hours getting the shot, I started having tightness in the chest along with a stabbing pain in my left shoulder blade. It was severe at times then it would subside a little.  I chewed on a aspirin to make the tightness go away and it seemed to help but then the pain would return.   This continued for around 48 hours then subsided.  I was seriously considering going to the ER, but I  didn't want to risk exposure to Covid by going to the ER.   I do have high blood pressure but I have NEVER felt anything like this.  I thought I was having a heart attack.  Other side effects were ones I read about but usually after the 2nd shot.  This was my FIRST shot.    I had a temperature of 100.6 although I was FREEZING.  My feet were cold to the touch and yet the thermometer read over 100.   Pain at the injection site ( it hurt like hell when the bedsheet touched my arm!   Alternated between burning up and freezing.
Pt came to clinic with 5 other family to receive COVID bivalent booster vaccine and influenza vaccine under RN's COVID Vax schedule. Vaccines were prepared correctly and marked per clinic protocol. Vaccines were separated in separate bins. Influenza vaccine prepared for family was private d/t pt having insurance. Front desk receptionist reported to RN that the father of the family paid in cash d/t insurance not covering flu vaccines. 3 doses of VFC flu vaccine were prepared for the 3 minors of the family, but the 3 doses of private flu vaccine were not disposed of. Vaccine records and consents were examined and verified by RN. Family was called back into the room where vaccine administration took place. All 6 family members in the room during vaccine administration. It became apparent that the pt received a dose of the VFC and private flu after administration because vaccines were counted and an extra COVID booster was left. Reviewed vaccine administration with family. Pt received VFC and privet flu instead of COVID booster. Informed the family of the administration error. Educated family of possible side effects d/t extra dose. Gave family VIS. Mother verbalized having daughter receive correct COVID booster. COVID booster administered. Family stayed in the clinic for 20 minutes after vaccine administration. RN assessed pt and family, pt and family discharged without any evidence of physical distress. Gave family clinic information and RN's business card, educated pt to call the clinic with any questions. Vaccines were documented in pt's chart. VAERS report completed. Called pt's mother on 12/21/2022 at 10:20 AM. Pt mother reports that pt has a fever and that she was given 400 mg of ibuprofen. Educated pt that fever is a common side effect of both vaccines and that she did receive an extra dose of flu vaccine. Educated pt about medication for fevers including ibuprofen and acetaminophen. Pt's mother reports that all other family members do not have side effects except older son that reports feeling "achy all over". Informed pt's mother to call the clinic with any questions.
This spontaneous report as received from a consumer via a twitter refers to his/her daughter of unknown age. On an unknown date the patient was vaccinated with GARDASIL, reported as "Merck HPV vaccine" (dose, frequency, route, lot# and expiration date unknown). On an unknown date the perfectly healthy patient died 2 weeks after vaccine acute liver failure. The reporter considered the vaccine murdered his/her daughter. Upon internal review, vaccine acute liver failure was considered to be medically significant. Additional information has been requested.
The day after the shot, I developed severe shoulder pain in my right shoulder and down the outside of my right arm, and limited movement in arm that received the Pneumovax 23 vaccine. More than 3 months later pain has lessened but still significant and somewhat limiting.  Doing physical therapy and anti inflammatories.  Orthopedic doctor said there is a recognized link between this shot and shoulder joint pain. He has another current patient and previous patients with similar condition.  Also patient has 2 friends that experienced a similar problem, one lasting for 6 months and has heard other examples of problems following the shot.  The Physical therapist also mentioned a link and previous experience with this type of injury.  There should be a warning in the literature before the shot is given.  One could at least have the shot in their non-dominant arm.  Literature provided with shot mentions only that you may get a redness and soreness at injection site for a short time.    Patients should be warned of the more severe risks which appear to be more common than reported. This is unacceptable and it appears that the injury is more widespread than is known by the general public.
Child given Flumist into (L) nose with difficulty. Become upset and blew his nose, then second part of Flumist given (R) nose. Had nose bleed for (R) side. Given Kleenex. Spoke to mom about pressure on (R) side of nose.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 11-AUG-2015, the patient was vaccinated with a dose of an improperly stored MMR II (albumin status: rHA; dose and route of administration were not reported; lot #L002873 and expiry date on 27-JAN-2017). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Patient presented at the pharmacist window approx 5-10mins after administration and said she did not feel well and felt very hot. She then went limp against the plexiglass and passed out. She came to pretty quickly and was able to talk coherently. She said she was hot and had not eaten anything. I have her cold water, cool compress, crackers. EMS arrived and took over. Before she left patient said she was feeling much better.
This spontaneous report as received from a consumer refers to herself a 74 year old female patient with allergy to "mycin" medication and unspecified antibiotics. The patient's medical history included shingles 3 times prior to having the vaccine. In 2006 the patient was vaccinated with ZOSTAVAX (dose/frequency as directed; route and lot number were not provided). Concomitant therapies included TOPAMAX. In 2014 the patient experienced shingles related neuralgia. The patient talked to her physician and the event was treated with capsaicin. The outcome of shingles related neuralgia was reported as not recovered/not resolved. The relatedness was not provided. Additional information is not expected.
Pneumococcal vaccine 23 valent administered on 02-NOV-2012 and pneumococcal vaccine 13 valent on 09-APR-2015; This spontaneous report has been received from a lawyer, via a Plaintiff Fact Sheet from a case in litigation for Zoster Vaccine Live (ZOSTAVAX) (MARRS# 1903USA012114), concerning a 64-year-old female patient. The patient's medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 02-NOV-2012, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (manufacturer unknown) (reported as PPSV23) and on 09-APR-2015, she received a dose of pneumococcal vaccine 13v (reported as PCV13) (inappropriate schedule of product administration), both administered as prophylaxis (strength, dosage schedule, route of administration, anatomical site of vaccination, vaccination scheme frequency, lot number, and expiration date were not reported for both doses). No adverse effects were reported.; Sender's Comments:  US-009507513-1903USA012114:
Soreness in injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness in injection site arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) and METFORMIN for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Soreness in injection site arm). The patient was treated with PARACETAMOL (TYLENOL) for Pain injection site, at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (Soreness in injection site arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up received on 25-JUN-2021:Outcome of event, and treatment medication added.
pt became lightheaded & pale about 5min p/vax;pt fainted for approx 10sec & returned to consciousness;approx 10min later pt vomited;no further problems;
Dizziness; Room is spinning/vertigo; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and VERTIGO (Room is spinning/vertigo) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and VERTIGO (Room is spinning/vertigo). The patient was treated with MECLIZINE [MECLOZINE] at a dose of 2.5 milligram. At the time of the report, DIZZINESS (Dizziness) and VERTIGO (Room is spinning/vertigo) had not resolved. Not Provided           This side effect presented itself about one week after the administration of the second dose and has continued up to this time. She went to her Doctor's office for treatment and was diagnosed with Vertigo and given medication. Side effects are still present currently.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow up information received on 18-May-2021 and no new information was added.
I?ve been disabled for more than a year due to what I reported on the previous page. However, after getting the vaccine, I?ve had fatigue, occasional shortness of breath, increased pain & anxiety, no appetite and issues with sleep. Since I don?t know if the vaccine has caused this I?m going to check with my psychiatrist (since I haven?t seen a doctor I?ll Mark none of the above below) but since it?s not improving, thought I should report it as well in case other people have had similar issues.
Swollen bleeding right tonsil. 2 days after dose. Saw pcp. Tested for strep. Negative test. Placed on penicillin for 10 days. Felt better after being on pcn for 7 days.
1st Covid vaccination received on 2/20/21, Both of the following caused significant bruising on both arms - blood  draw on 2/26/21 and CT with contrast on 3/2/21. Unusual for me.
Complained of difficulty swallowing that quickly progressed to difficulty breathing and answering questions. Taken to ER at 1540.
* patient started vomiting about 7-10 minutes after vaccination; he recovered without incidence in about 10-15 minutes
only diluent as administered to a patient a week ago; only diluent as administered to a patient a week ago; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 73-year-old female patient who received Herpes zoster (Shingrix) (expiry date 27-SEP-2025) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: only diluent as administered to a patient a week ago) and inappropriate dose of vaccine administered (Verbatim: only diluent as administered to a patient a week ago). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 7-NOV-2023 A pharmacist reported that only diluent was administered to a patient a week ago.  That was Dose 1. The reporter consented to follow up. The patient received a dose of Shingrix diluent alone, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Sore arm where he got the injection for 2-3 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm where he got the injection for 2-3 days) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm where he got the injection for 2-3 days). At the time of the report, VACCINATION SITE PAIN (Sore arm where he got the injection for 2-3 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.
None- vaccine given 12 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 12 days post expiry) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 12 days post expiry). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 12 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-395985 (Patient Link).